Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage.

Barsky, Benjamin A; Busch, Alisa B; Patel, Sadiq Y; Mehrotra, Ateev; Huskamp, Haiden A

Barsky, Benjamin A; Busch, Alisa B; Patel, Sadiq Y; Mehrotra, Ateev; Huskamp, Haiden A.

Barsky BA; Interfaculty Initiative in Health Policy, Harvard University, Cambridge, Massachusetts.
Busch AB; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Patel SY; Hospital Administration, McLean Hospital, Belmont, Massachusetts.
Mehrotra A; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Huskamp HA; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.

JAMA Netw Open ; 5(1): e2142531, 2022 01 04.

Article in English | MEDLINE | ID: covidwho-1615906

Subject(s)

Buprenorphine/therapeutic use; COVID-19; Drug Prescriptions; Opioid-Related Disorders/drug therapy; Pandemics; Practice Patterns, Physicians'/legislation & jurisprudence; Telemedicine/legislation & jurisprudence; Adult; Aged; Aged, 80 and over; Cross-Sectional Studies; Female; Humans; Insurance Coverage; Legislation, Medical; Male; Medicare Part C; Middle Aged; Narcotic Antagonists/therapeutic use; United States; Young Adult

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Drug Prescriptions / Practice Patterns, Physicians' / Buprenorphine / Telemedicine / Pandemics / COVID-19 / Opioid-Related Disorders Type of study: Observational study / Prognostic study / Randomized controlled trials Limits: Adult / Aged / Female / Humans / Male / Middle aged / Young adult Country/Region as subject: North America Language: English Journal: JAMA Netw Open Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google